Headquartered in Millbrae, California, Luma Therapeutics is a medical device company founded with a vision to end the suffering of people with inflammatory skin conditions, starting with psoriasis. In the United States alone there are 7.5 million people suffering from psoriasis and it affects 120 million people worldwide. Evan Anderson, our Founder and CEO, is a psoriasis patient. After trying multiple existing options for treating his own psoriasis, Evan began tinkering with coal tar, occlusive dressings and light therapy inspired by the incredible clinical results of the Goeckerman regimen. The result is Luma's first product, illuvinate.illuvinate is Luma's recently launched treatment for psoriasis. It is an FDA-cleared, home-use product and is now available in Northern California. Results are seen in as little as 6 weeks.